Niagen Bioscience (NAGE) Revenue & Revenue Breakdown
Niagen Bioscience Revenue Highlights
Latest Revenue (Y)
$99.60M
Latest Revenue (Q)
$29.13M
Niagen Bioscience Revenue by Period
Niagen Bioscience Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $99.60M | 19.18% |
| 2023-12-31 | $83.57M | 15.99% |
| 2022-12-31 | $72.05M | 6.82% |
| 2021-12-31 | $67.45M | 13.82% |
| 2020-12-31 | $59.26M | 28.01% |
| 2019-12-31 | $46.29M | 46.69% |
| 2018-12-31 | $31.56M | 48.85% |
| 2017-12-31 | $21.20M | -2.14% |
| 2016-12-31 | $21.66M | 21.13% |
| 2015-12-31 | $17.88M | 16.79% |
| 2014-12-31 | $15.31M | 50.71% |
| 2013-12-31 | $10.16M | -12.48% |
| 2012-12-31 | $11.61M | 43.12% |
| 2011-12-31 | $8.11M | 7.22% |
| 2010-12-31 | $7.57M | - |
Niagen Bioscience generated $99.60M in revenue during NA 2024, up 19.18% compared to the previous quarter, and up 215.15% compared to the same period a year ago.
Niagen Bioscience Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $29.13M | 13.86% |
| 2024-09-30 | $25.58M | 12.49% |
| 2024-06-30 | $22.74M | 2.65% |
| 2024-03-31 | $22.15M | 4.52% |
| 2023-12-31 | $21.20M | 8.73% |
| 2023-09-30 | $19.50M | -4.07% |
| 2023-06-30 | $20.32M | -9.90% |
| 2023-03-31 | $22.56M | 7.43% |
| 2022-12-31 | $21.00M | 23.05% |
| 2022-09-30 | $17.06M | 1.98% |
| 2022-06-30 | $16.73M | -3.05% |
| 2022-03-31 | $17.26M | -2.82% |
| 2021-12-31 | $17.76M | 2.61% |
| 2021-09-30 | $17.31M | -2.21% |
| 2021-06-30 | $17.70M | 20.54% |
| 2021-03-31 | $14.68M | -4.93% |
| 2020-12-31 | $15.45M | 8.92% |
| 2020-09-30 | $14.18M | -7.24% |
| 2020-06-30 | $15.29M | 6.57% |
| 2020-03-31 | $14.35M | 9.60% |
| 2019-12-31 | $13.09M | 8.60% |
| 2019-09-30 | $12.05M | 8.58% |
| 2019-06-30 | $11.10M | 10.48% |
| 2019-03-31 | $10.05M | 10.82% |
| 2018-12-31 | $9.07M | 11.66% |
| 2018-09-30 | $8.12M | 4.06% |
| 2018-06-30 | $7.80M | 18.82% |
| 2018-03-31 | $6.57M | -12.80% |
| 2017-12-31 | $7.53M | 23.78% |
| 2017-09-30 | $6.08M | 44.24% |
| 2017-06-30 | $4.22M | 25.24% |
| 2017-03-31 | $3.37M | -40.31% |
| 2016-12-31 | $5.64M | 43.30% |
| 2016-09-30 | $3.94M | -55.41% |
| 2016-06-30 | $8.83M | 20.43% |
| 2016-03-31 | $7.33M | 67.99% |
| 2015-12-31 | $4.36M | -30.58% |
| 2015-09-30 | $6.29M | 3.05% |
| 2015-06-30 | $6.10M | 15.97% |
| 2015-03-31 | $5.26M | 23.99% |
| 2014-12-31 | $4.24M | 2.50% |
| 2014-09-30 | $4.14M | 7.35% |
| 2014-06-30 | $3.86M | 25.44% |
| 2014-03-31 | $3.07M | 28.02% |
| 2013-12-31 | $2.40M | -11.66% |
| 2013-09-30 | $2.72M | 0.42% |
| 2013-06-30 | $2.71M | 15.95% |
| 2013-03-31 | $2.33M | -33.73% |
| 2012-12-31 | $3.52M | -3.02% |
| 2012-09-30 | $3.63M | 36.01% |
| 2012-06-30 | $2.67M | 49.61% |
| 2012-03-31 | $1.79M | -1.26% |
| 2011-12-31 | $1.81M | -1.08% |
| 2011-09-30 | $1.83M | -5.70% |
| 2011-06-30 | $1.94M | -23.68% |
| 2011-03-31 | $2.54M | 24.93% |
| 2010-12-31 | $2.03M | 30.10% |
| 2010-09-30 | $1.56M | -23.18% |
| 2010-06-30 | $2.03M | 4.97% |
| 2010-03-31 | $1.94M | - |
Niagen Bioscience generated $29.13M in revenue during Q4 2024, up 13.86% compared to the previous quarter, and up 149.40% compared to the same period a year ago.